MITech Co Ltd
KOSDAQ:179290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MITech Co Ltd
Capital Expenditures
MITech Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MITech Co Ltd
KOSDAQ:179290
|
Capital Expenditures
-₩3.9B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Capital Expenditures
-₩28.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-8%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Capital Expenditures
-₩19.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-81%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Capital Expenditures
-₩2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Capital Expenditures
-₩1.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Capital Expenditures
-₩406.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MITech Co Ltd
Glance View
M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.
See Also
What is MITech Co Ltd's Capital Expenditures?
Capital Expenditures
-3.9B
KRW
Based on the financial report for Sep 30, 2025, MITech Co Ltd's Capital Expenditures amounts to -3.9B KRW.
What is MITech Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
3%
Over the last year, the Capital Expenditures growth was -300%. The average annual Capital Expenditures growth rates for MITech Co Ltd have been -96% over the past three years , 3% over the past five years .
